Virios Therapeutics Inc. (VIRI)

AI Score

Unlock

0.15

0.01 (8.77%)

At close: Oct 08, 2024, 8:00 PM

Virios Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q4 2019	Q3 2019
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019
Cash & Equivalents	3.02M	2.38M	3.32M	4.79M	4.59M	5.33M	7.03M	9.79M	7.7M	11.35M	14.01M	19.19M	21.84M	24.59M	29.8M	499.08K	1.05M	-309.38K	309.38K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	618.77K	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	225.28K	60K	-309.38K	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	324.00	n/a	n/a	n/a	785.00
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-324	n/a	93.4K	n/a	n/a
Other Current Assets	35.07K	52.24K	3.56K	18.82K	32.11K	53.91K	7.29K	13.68K	25.38K	34.07K	863.00	21.08K	757.00	3.69M	n/a	61.01K	n/a	n/a	n/a
Total Current Assets	3.64M	3.22M	4.17M	5.25M	4.59M	5.33M	8.37M	10.86M	9.04M	12.55M	15.78M	20.11M	23.76M	24.59M	31.47M	560.1K	1.21M	309.38K	315.9K
Property-Plant & Equipment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	n/a	n/a	n/a	n/a	621.99K	1.19M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	3.69M	n/a	225.28K	60K	-309.38K	n/a
Total Assets	3.64M	3.22M	4.17M	5.25M	5.21M	6.52M	8.37M	10.86M	9.04M	12.55M	15.78M	20.11M	23.76M	28.27M	31.47M	785.37K	1.27M	n/a	315.9K
Account Payables	217.76K	196.76K	111.91K	205.37K	214.31K	135.09K	573.16K	679.42K	665.54K	330.69K	353.86K	483.5K	262.59K	614.66K	368.9K	199.37K	198.25K	n/a	35.42K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	44.19K	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	55.92K	93.97K	n/a	46.8K	62.73K	93.15K	159.7K	261.35K	346.5K	236.85K	532.68K	459.06K	345.31K	226.93K	573.48K	34.65K	19.52K	n/a	n/a
Total Current Liabilities	500.07K	570.08K	358.55K	487.14K	520.03K	549.29K	1.04M	1.63M	1.9M	1.88M	1.28M	1.23M	906.26K	1.17M	1.53M	1.78M	1.85M	n/a	1.62M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.15M	5.49M	n/a	3.64M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	135.09K	573.16K	679.42K	665.54K	330.69K	353.86K	n/a	n/a	n/a	n/a	4.15M	5.49M	n/a	3.64M
Total Liabilities	500.07K	570.08K	358.55K	487.14K	520.03K	549.29K	1.04M	1.63M	1.9M	1.88M	1.28M	1.23M	906.26K	1.17M	1.53M	5.94M	7.34M	n/a	5.26M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.15M	5.49M	n/a	3.64M
Common Stock	2.78K	1.93K	1.93K	1.93K	1.86K	1.83K	1.83K	1.83K	833.00	833.00	833.00	833.00	833.00	833.00	830.00	16.24M	12.6M	n/a	12.6M
Retained Earnings	-63.81M	-62.76M	-61.47M	-60.37M	-59.13M	-57.69M	-56.17M	-54.13M	-51.55M	-47.89M	-43.93M	-39.41M	-35.3M	-31.02M	-27.97M	-21.46M	-18.74M	n/a	-17.62M
Comprehensive Income	n/a	-0.00	0.00	0.00	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	0.00	n/a	0.00	0.00	-5.02M	n/a
Shareholders Equity	3.14M	2.65M	3.81M	4.76M	4.69M	5.97M	7.33M	9.22M	7.14M	10.67M	14.5M	18.88M	22.86M	27.11M	29.94M	-5.15M	-6.06M	-4.94M	-4.94M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	618.77K	n/a